Close

Bio-Path Holdings (BPTH) Receives EMA Orphan Drug Designation for BP1001 as AML Treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. HCP
6. SPY
7. BSX
8. PI
9. NOW
10. BA


Go back to Bio-Path Holdings (BPTH) Receives EMA Orphan Drug Designation for BP1001 as AML Treatment